Biotech Co. Hits Ch. 11, Blames Drug Misfires, Criminal Case
DMK Pharmaceuticals has applied for Chapter 11 protection in Delaware, citing recent clinical trial failures and product recalls, as well as the government's allegation that a subsidiary engaged in criminal activities,...To view the full article, register now.
Already a subscriber? Click here to view full article